Nuclear translocation of glutathione transferase omega is a progression marker in Barrett's esophagus

Simona Piaggi; Santino Marchi; Eugenio Ciancia; Nicola Debortoli; Alessandra Lazzarotti; Michela Saviozzi; Chiara Raggi; Vanna Fierabracci; Athanase Visvikis; Hanne C Bisgaard; Alessandro F Casini; Aldo Paolicchi

Nuclear translocation of glutathione transferase omega is a progression marker in Barrett's esophagus

Simona Piaggi, Santino Marchi, Eugenio Ciancia, Nicola Debortoli, Alessandra Lazzarotti, Michela Saviozzi, Chiara Raggi, Vanna Fierabracci, Athanase Visvikis, Hanne C Bisgaard, Alessandro F Casini, Aldo Paolicchi

Department of Cellular and Molecular Medicine

8 Citations (Scopus)

Abstract

Barrett's esophagus (BE) represents a major risk factor for esophageal adenocarcinoma (AC). For this reason, patients with BE are subjected to a systematic endoscopic surveillance to detect initial evolution towards non-invasive neoplasia (NiN) and cancer, that eventually occurs only in a small fraction of BE patients. This study was aimed to investigate the possible role of glutathione-S-transferase-omega 1 (GSTO1), a recently discovered member of the glutathione-S-transferase family, as a progression marker in the Barrett's disease in order to improve the diagnosis of NiN in BE and to understand the mechanisms of the progression from BE to AC. We investigated the expression and subcellular localization of GSTO1 in biopsies from patients with BE and in human cancer cell lines subjected to heath shock treatment. A selective nuclear localisation of GSTO1 was found in 16/16 biopsies with low- or high-grade NiN, while it appeared in only 4/22 BE biopsies without signs of NiN (P<0.0001). Among biopsies of BE without NiN, diffuse (nuclear and cytoplasmic) staining was found in 5/22 cases, while selective cytoplasmic localisation was found in 13/22. The 6 cases with indefinite grade of NiN were equally divided between nuclear, cytoplasmic and diffuse staining (2 each, respectively). Experiments in vitro showed that in human HeLa cancer cells, GSTO1 translocates into the nucleus as a consequence of heath shock. These findings suggested that the nuclear translocation of glutathione-S-transferase-omega 1 could be involved in the stress response of human cells playing a role in the cancer progression of Barrett's esophagus. Its immunohistochemical detection could represent a useful tool in the grading of Barrett's disease.

Original language	English
Journal	Oncology Reports
Volume	21
Issue number	2
Pages (from-to)	283-7
Number of pages	4
ISSN	1021-335X
Publication status	Published - 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{76ec0f00987d11df928f000ea68e967b,

title = "Nuclear translocation of glutathione transferase omega is a progression marker in Barrett's esophagus",

abstract = "Barrett's esophagus (BE) represents a major risk factor for esophageal adenocarcinoma (AC). For this reason, patients with BE are subjected to a systematic endoscopic surveillance to detect initial evolution towards non-invasive neoplasia (NiN) and cancer, that eventually occurs only in a small fraction of BE patients. This study was aimed to investigate the possible role of glutathione-S-transferase-omega 1 (GSTO1), a recently discovered member of the glutathione-S-transferase family, as a progression marker in the Barrett's disease in order to improve the diagnosis of NiN in BE and to understand the mechanisms of the progression from BE to AC. We investigated the expression and subcellular localization of GSTO1 in biopsies from patients with BE and in human cancer cell lines subjected to heath shock treatment. A selective nuclear localisation of GSTO1 was found in 16/16 biopsies with low- or high-grade NiN, while it appeared in only 4/22 BE biopsies without signs of NiN (P<0.0001). Among biopsies of BE without NiN, diffuse (nuclear and cytoplasmic) staining was found in 5/22 cases, while selective cytoplasmic localisation was found in 13/22. The 6 cases with indefinite grade of NiN were equally divided between nuclear, cytoplasmic and diffuse staining (2 each, respectively). Experiments in vitro showed that in human HeLa cancer cells, GSTO1 translocates into the nucleus as a consequence of heath shock. These findings suggested that the nuclear translocation of glutathione-S-transferase-omega 1 could be involved in the stress response of human cells playing a role in the cancer progression of Barrett's esophagus. Its immunohistochemical detection could represent a useful tool in the grading of Barrett's disease.",

author = "Simona Piaggi and Santino Marchi and Eugenio Ciancia and Nicola Debortoli and Alessandra Lazzarotti and Michela Saviozzi and Chiara Raggi and Vanna Fierabracci and Athanase Visvikis and Bisgaard, {Hanne C} and Casini, {Alessandro F} and Aldo Paolicchi",

note = "Keywords: Barrett Esophagus; Blotting, Western; Cell Nucleus; Disease Progression; Esophageal Neoplasms; Female; Fluorescent Antibody Technique; Glutathione Transferase; Hela Cells; Humans; Immunohistochemistry; Male; Middle Aged; Precancerous Conditions; Protein Transport; Tumor Markers, Biological",

year = "2009",

language = "English",

volume = "21",

pages = "283--7",

journal = "Oncology Reports",

issn = "1021-335X",

publisher = "Spandidos Publications",

number = "2",

}

TY - JOUR

T1 - Nuclear translocation of glutathione transferase omega is a progression marker in Barrett's esophagus

AU - Piaggi, Simona

AU - Marchi, Santino

AU - Ciancia, Eugenio

AU - Debortoli, Nicola

AU - Lazzarotti, Alessandra

AU - Saviozzi, Michela

AU - Raggi, Chiara

AU - Fierabracci, Vanna

AU - Visvikis, Athanase

AU - Bisgaard, Hanne C

AU - Casini, Alessandro F

AU - Paolicchi, Aldo

N1 - Keywords: Barrett Esophagus; Blotting, Western; Cell Nucleus; Disease Progression; Esophageal Neoplasms; Female; Fluorescent Antibody Technique; Glutathione Transferase; Hela Cells; Humans; Immunohistochemistry; Male; Middle Aged; Precancerous Conditions; Protein Transport; Tumor Markers, Biological

PY - 2009

Y1 - 2009

N2 - Barrett's esophagus (BE) represents a major risk factor for esophageal adenocarcinoma (AC). For this reason, patients with BE are subjected to a systematic endoscopic surveillance to detect initial evolution towards non-invasive neoplasia (NiN) and cancer, that eventually occurs only in a small fraction of BE patients. This study was aimed to investigate the possible role of glutathione-S-transferase-omega 1 (GSTO1), a recently discovered member of the glutathione-S-transferase family, as a progression marker in the Barrett's disease in order to improve the diagnosis of NiN in BE and to understand the mechanisms of the progression from BE to AC. We investigated the expression and subcellular localization of GSTO1 in biopsies from patients with BE and in human cancer cell lines subjected to heath shock treatment. A selective nuclear localisation of GSTO1 was found in 16/16 biopsies with low- or high-grade NiN, while it appeared in only 4/22 BE biopsies without signs of NiN (P<0.0001). Among biopsies of BE without NiN, diffuse (nuclear and cytoplasmic) staining was found in 5/22 cases, while selective cytoplasmic localisation was found in 13/22. The 6 cases with indefinite grade of NiN were equally divided between nuclear, cytoplasmic and diffuse staining (2 each, respectively). Experiments in vitro showed that in human HeLa cancer cells, GSTO1 translocates into the nucleus as a consequence of heath shock. These findings suggested that the nuclear translocation of glutathione-S-transferase-omega 1 could be involved in the stress response of human cells playing a role in the cancer progression of Barrett's esophagus. Its immunohistochemical detection could represent a useful tool in the grading of Barrett's disease.

AB - Barrett's esophagus (BE) represents a major risk factor for esophageal adenocarcinoma (AC). For this reason, patients with BE are subjected to a systematic endoscopic surveillance to detect initial evolution towards non-invasive neoplasia (NiN) and cancer, that eventually occurs only in a small fraction of BE patients. This study was aimed to investigate the possible role of glutathione-S-transferase-omega 1 (GSTO1), a recently discovered member of the glutathione-S-transferase family, as a progression marker in the Barrett's disease in order to improve the diagnosis of NiN in BE and to understand the mechanisms of the progression from BE to AC. We investigated the expression and subcellular localization of GSTO1 in biopsies from patients with BE and in human cancer cell lines subjected to heath shock treatment. A selective nuclear localisation of GSTO1 was found in 16/16 biopsies with low- or high-grade NiN, while it appeared in only 4/22 BE biopsies without signs of NiN (P<0.0001). Among biopsies of BE without NiN, diffuse (nuclear and cytoplasmic) staining was found in 5/22 cases, while selective cytoplasmic localisation was found in 13/22. The 6 cases with indefinite grade of NiN were equally divided between nuclear, cytoplasmic and diffuse staining (2 each, respectively). Experiments in vitro showed that in human HeLa cancer cells, GSTO1 translocates into the nucleus as a consequence of heath shock. These findings suggested that the nuclear translocation of glutathione-S-transferase-omega 1 could be involved in the stress response of human cells playing a role in the cancer progression of Barrett's esophagus. Its immunohistochemical detection could represent a useful tool in the grading of Barrett's disease.

M3 - Journal article

C2 - 19148497

SN - 1021-335X

VL - 21

SP - 283

EP - 287

JO - Oncology Reports

JF - Oncology Reports

IS - 2

ER -

Nuclear translocation of glutathione transferase omega is a progression marker in Barrett's esophagus

Abstract

UN SDGs

Fingerprint

Cite this